loading.........
Sydney, April 20, 2018 AEST (ABN Newswire) - Martin Rogers from KTM Ventures Innovation Fund Explains Cryptocurrency Exchanges at the PlayUp Global Fantasy Sports ICO Launch in Sydney on April 16th, 2018.
Martin Rogers is a successful start-up investor and company director. Martin has Chemical Engineering and Computer Science degrees and has a depth of experience in incubating companies and publicly listed organisations.
Martin has experience in all aspects of financial, strategic and operational management. Martin has been both an investor and senior executive in a private funded advisory business in the tech, science and life sciences sectors, where he was instrumental in significantly increasing the value of those investments.
Martin was instrumental in the establishment of KTM Ventures, an ESVCLP (Early Stage Venture Capital Limited Partnership) incorporated under Australian law with tax advantages to venture investors. KTM Ventures provides potentially higher investment returns in a tax-effective fund focused upon pre-IPO and private expansion capital.
Martin's recent board positions include: Chairman, Actinogen (
ASX:ACW) and Rhinomed (ASX:RNO), Non-Executive Director OncoSil Medical (ASX:OSL) and Cellmid (ASX:CDY). Prior to this Martin was the CEO for Prima BioMed Ltd (ASX:PRR).
To view KTM Ventures Innovation Fund, please visit:
http://ktmcapital.com.au/ktm-ventures/
Australia's First Regulated Cryptocurrency Exchange:
http://www.independentreserve.com
To view the Video Webcast, please visit:
http://www.abnnewswire.net/press/en/92837/KTM
To view Martins Full Presentation PDF, please visit:
http://abnnewswire.net/lnk/EDY9737G
About Investorium.tv
Related Companies
PlayChip
Mission NewEnergy Limited
Investorium.tv
Martin Rogers is a successful start-up investor and company director. Martin has Chemical Engineering and Computer Science degrees and has a depth of experience in incubating companies and publicly listed organisations.
Martin has experience in all aspects of financial, strategic and operational management. Martin has been both an investor and senior executive in a private funded advisory business in the tech, science and life sciences sectors, where he was instrumental in significantly increasing the value of those investments.
Martin was instrumental in the establishment of KTM Ventures, an ESVCLP (Early Stage Venture Capital Limited Partnership) incorporated under Australian law with tax advantages to venture investors. KTM Ventures provides potentially higher investment returns in a tax-effective fund focused upon pre-IPO and private expansion capital.
Martin's recent board positions include: Chairman, Actinogen (
ASX:ACW) and Rhinomed (ASX:RNO), Non-Executive Director OncoSil Medical (ASX:OSL) and Cellmid (ASX:CDY). Prior to this Martin was the CEO for Prima BioMed Ltd (ASX:PRR).To view KTM Ventures Innovation Fund, please visit:
http://ktmcapital.com.au/ktm-ventures/
Australia's First Regulated Cryptocurrency Exchange:
http://www.independentreserve.com
To view the Video Webcast, please visit:
http://www.abnnewswire.net/press/en/92837/KTM
To view Martins Full Presentation PDF, please visit:
http://abnnewswire.net/lnk/EDY9737G
About Investorium.tv
Investorium.tv is a Video Streaming and Live Financial Industry Event featuring CEOs of Public Companies held at Premier Venues in New York, Vancouver and Sydney. Investorium.tv records and video streams the events on "state of the art" digital recording and webcasting equipment, making high definition broadcast quality productions available to Members and the professional investment community.
|
||
|
Related Companies
PlayChip
Mission NewEnergy Limited
Investorium.tv
ABN Newswire
